Connect with us

Hi, what are you looking for?

Stock

Pharmacy benefit manager stocks dip following Trump’s vow to cut drug costs

In the wake of President-elect Donald Trump’s recent declaration to eliminate the “middle man” in an effort to reduce prescription drug costs, shares of companies that own pharmacy benefit managers (PBMs) experienced a downturn on Monday. Key industry players such as CVS Health (NYSE:CVS)’s Caremark, Cigna (NYSE:CI)’s Express Scripts, and UnitedHealth Group (NYSE:UNH)’s Optum, which collectively dominate the PBM market in the United States, saw their stock prices fall after Trump’s remarks to the press at Mar-a-Lago today.

The statement from Trump aligns with bipartisan efforts to address the role of PBMs in the healthcare industry. Last week, a bill was introduced by U.S. Senators Elizabeth Warren and Josh Hawley, representing both the Democratic and Republican parties, respectively. The proposed legislation aims to compel health insurers or drug middlemen to separate from their pharmacy operations within a three-year period. This bill, which also has the backing of Representatives Diana Harshbarger and Jake Auchincloss from the Republican and Democratic parties, is set to be presented in Congress.

PBMs have become a focal point of scrutiny as they play a crucial role in negotiating drug prices between various parties including insurers, pharmacies, and drug manufacturers. They are also responsible for reimbursing pharmacies for prescription drugs covered under their plans.

The market’s reaction to Trump’s remarks was evident as CVS’s stock declined by 3%, Cigna’s by 1.2%, and UnitedHealth’s by 2.8% on Monday afternoon. These movements underscore the growing political and regulatory pressures facing PBMs as legislators from both major parties push for reforms in the pharmaceutical industry.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    Former president Donald Trump and his allies have filed hundreds of lawsuits, with more to come, seeking to tighten voting rules or disqualify voters....

    Economy

    LONDON (Reuters) – Bank of England interest rate-setter Megan Greene said she still believed the central bank should take a cautious approach to cutting...

    Editor's Pick

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Latest News

    Warner Bros. Discovery said Thursday its streaming platform Max added 7.2 million global subscribers in the third quarter. It marked the biggest quarterly growth for...

    Disclaimer: beneficialinvestmentnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 beneficialinvestmentnow.com